美股新聞 標題聯播 · 近 24 小時 337 則 · 29 個來源 · 最新 9/20 04:53
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · BDSX近 30 天 6 則 · 第 1 / 1 頁
- Biodesix (BDSX) Stock Gets Fair Value Boost On Revenue And Margin Optimism
- Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings
- Biodesix to Participate in Upcoming Investor Conferences
- What Makes Biodesix, Inc. (BDSX) a Strong Momentum Stock: Buy Now?
- Wall Street Analysts See a 26.72% Upside in Biodesix (BDSX): Can the Stock Really Move This High?
- PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?
- Biodesix (BDSX) Q2 2026 Earnings Call Transcript
- Biodesix Sees Nodify Growth, Reaffirms Revenue Outlook at Canaccord Conference
- Has Agilon Health (AGL) Outpaced Other Medical Stocks This Year?
- Biodesix, Inc. (BDSX) Hit a 52 Week High, Can the Run Continue?
- Wall Street Analysts Think Biodesix (BDSX) Could Surge 31.91%: Read This Before Placing a Bet
- Biodesix, Inc. Q2 2026 Earnings Call Summary
- Biodesix Inc (BDSX) (Q2 2026) Earnings Call Highlights: Revenue Surges 34% on Strong Diagnostic ...
- Biodesix Q2 Earnings Call Highlights
- Biodesix, Inc. (BDSX) Reports Q2 Loss, Beats Revenue Estimates
- Biodesix Announces Second Quarter 2026 Results and Highlights
- Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
- BIAF vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?
- Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026
- Can Elevance Recover $115 Million Through Its CMS Lawsuit?
- Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year?
- Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?
- Are Medical Stocks Lagging Aura Biosciences (AURA) This Year?
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。